Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000138:chemical synthesis* / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007546:Isoquinolines / Q000138:chemical synthesis / Q000494:pharmacology; D008297:Male; D010617:Phenanthridines / Q000138:chemical synthesis / Q000494:pharmacology; D011412:Propanolamines / Q000138:chemical synthesis* / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011804:Quinolines / Q000138:chemical synthesis / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007546:Isoquinolines; D010617:Phenanthridines; D011412:Propanolamines; D011804:Quinolines; D011433:Propranolol; D007545:Isoproterenol